Clinical Trial Update: An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures [Phase 3]

View source ↗

Summary

This is a completed Phase 3 open-label study of levetiracetam (L059) in Japanese epilepsy patients with generalized tonic-clonic seizures. Results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Generalized Tonic-clonic Seizures

Drugs mentioned

• Keppra (levetiracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsy, Generalized Tonic-clonic Seizures | Phase 3 | Status: COMPLETED | Results posted: 2017-03-09